Responses
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
66 Complex markers of survival from pembrolizumab: the potential predictive role of tumor mutational burden (TMB) and KRAS
Compose a Response to This Article
Other responses
No responses have been published for this article.